Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010470 |
---|---|
Receipt number | R000012171 |
Scientific Title | Evaluation of the Feasible dose of Lenalidomide as maintenance therapy after Allogeneic hematopoietic stem cell Transplantation for multiple myeloma |
Date of disclosure of the study information | 2013/04/11 |
Last modified on | 2020/04/27 08:56:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/11 17:36:10 | ||
2 | Update | 2014/04/22 23:13:01 | Public title Acronym |
|
3 | Update | 2014/04/22 23:25:01 | TEL TEL Organization Organization |
|
4 | Update | 2016/10/27 17:29:14 | Key inclusion criteria |
|
5 | Update | 2016/10/27 17:30:09 | Name of primary person or sponsor Organization |
|
6 | Update | 2020/04/27 08:52:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Email3 Organization Organization Address Address Tel |
|
7 | Update | 2020/04/27 08:55:18 | Recruitment status Date of IRB Last follow-up date |
|
8 | Update | 2020/04/27 08:56:28 | Number of participants that the trial has enrolled |